Great Valley Advisor Group, Inc. Cerus Corp Transaction History

Great Valley Advisor Group, Inc.

  • $3.84 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022
BUY
$4.41 - $5.69 $1,203 - $1,553
273 Added 2.33%
11,973 $63,000
Q3 2020

Oct 21, 2020
BUY
$5.78 - $7.47 $8,670 - $11,205
1,500 Added 14.71%
11,700 $73,000
Q2 2020

Jul 31, 2020
BUY
$4.5 - $7.02 $45,900 - $71,604
10,200 New
10,200 $67,000

Others Institutions Holding CERS

# of Institutions
156
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $322M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Great Valley Advisor Group, Inc. Portfolio

Follow Great Valley Advisor Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email